Prothena Plc Correlations
PRTA Stock | USD 14.53 0.75 5.44% |
The current 90-days correlation between Prothena plc and Seres Therapeutics is 0.28 (i.e., Modest diversification). The correlation of Prothena Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Prothena Plc Correlation With Market
Very weak diversification
The correlation between Prothena plc and DJI is 0.5 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prothena plc and DJI in the same portfolio, assuming nothing else is changed.
Prothena |
Moving together with Prothena Stock
0.72 | ME | 23Andme Holding | PairCorr |
0.76 | VALN | Valneva SE ADR | PairCorr |
0.67 | VCNX | Vaccinex | PairCorr |
0.76 | DRMA | Dermata Therapeutics | PairCorr |
0.68 | DRRX | Durect | PairCorr |
0.83 | DTIL | Precision BioSciences | PairCorr |
0.81 | VINC | Vincerx Pharma | PairCorr |
0.63 | VRAX | Virax Biolabs Group | PairCorr |
0.78 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.67 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.63 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.74 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Prothena Stock
0.63 | DRUG | Bright Minds Biosciences | PairCorr |
0.61 | SABSW | SAB Biotherapeutics | PairCorr |
0.58 | VCYT | Veracyte | PairCorr |
0.48 | VERA | Vera Therapeutics | PairCorr |
0.42 | DMAC | DiaMedica Therapeutics | PairCorr |
0.34 | VANI | Vivani Medical | PairCorr |
0.33 | VCEL | Vericel Corp Ord | PairCorr |
0.74 | VRNA | Verona Pharma PLC | PairCorr |
0.67 | VSTM | Verastem Trending | PairCorr |
0.5 | VTRS | Viatris | PairCorr |
0.39 | DVAX | Dynavax Technologies | PairCorr |
0.34 | VRDN | Viridian Therapeutics | PairCorr |
0.32 | VTVT | vTv Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Prothena Stock performing well and Prothena Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prothena Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SCPH | 2.75 | (0.63) | 0.00 | (0.28) | 0.00 | 4.30 | 20.70 | |||
MIST | 2.00 | 0.27 | 0.13 | 0.27 | 1.93 | 7.19 | 18.66 | |||
ONCY | 3.46 | 0.06 | (0.03) | 0.01 | 3.55 | 7.83 | 36.56 | |||
MCRB | 5.09 | 0.30 | 0.04 | 0.76 | 5.68 | 10.84 | 28.84 | |||
LIFE | 2.57 | 0.20 | 0.10 | 0.21 | 2.62 | 6.45 | 28.98 | |||
ETNB | 2.77 | (0.33) | 0.00 | (0.02) | 0.00 | 5.01 | 27.43 | |||
MDGL | 2.72 | 0.44 | 0.15 | 1.31 | 2.20 | 5.17 | 30.27 | |||
PLRX | 2.98 | 0.01 | 0.03 | 0.11 | 3.22 | 6.15 | 24.35 | |||
ACLX | 2.56 | 0.21 | 0.10 | 0.20 | 2.98 | 6.65 | 15.13 | |||
STOK | 2.62 | (0.44) | 0.00 | (0.24) | 0.00 | 4.60 | 21.35 |
Prothena Plc Corporate Management
Hideki MD | Chief Officer | Profile | |
CPA CPA | Chief Controller | Profile | |
Jennifer Zibuda | Director Communication | Profile | |
Brandon Smith | Chief Officer | Profile | |
Wagner Zago | Chief Scientific Officer | Profile | |
Carol Karp | Chief Regulatory Officer | Profile | |
David Ford | Chief Officer | Profile |